MICs for 90% (MIC90s) of 75 Bordetella pertussis strains for amoxicillin, erythromycin, rifampin, and sulfamethoxazole-trimethoprim were 1, <0.12, 1, and 4 ,ug/ml, respectively. Susceptibility rates were all >93%. Only 17% of the strains were susceptible to tetracycline. The MIC90s of ciprofloxacin, enoxacin, norfloxacin, ofloxacin, and roxithromycin were .0.06, 0.5, 0.25, 0.12, and 0.5 ,ug/ml, respectively. For B. parapertussis, the MIC90s were 16-fold higher with amoxicillin and rifampiq and 2-to 4-fold higher with the fluoroquinolones and roxithromycin.
used for transportation of nasopharyngeal swabs and enrichment cultures. Regan-Lowe agar and Bordet Gengou agar (Difco LaPoratories, Detroit, Mich.) with 40 jig of cephalexin per ml were used a,s isolation media. Isolates were selected from separate households to increase the chance of variability in susceptibilities to the antimicrobial agents tested. Subculturing was restricted to avoid phase changes to resistant forms (3) . Standard criteria were used for identification (9) . Inocula from primary or subculture plates (3 to 4 days old) were transferred to heart infusion broth containing 0.1% agar or to sheep blood and then were stored at -700C. B Interpretive MIC criteria indicating susceptibility (S), moderate susceptibility (MS), and resistance (R) for the following antibiotics were taken from the NCCLS recommendations (16) and were as follows: amoxicillin: S, '1 ,ug/ml; MS, 2 to 16 ,ug/ml; and R, >16 jig/ml; erythromycin: S, .0.5 jig/ml; MS, 1 to 4 [ag/ml; and R, >4 ,uglml; SXT: S, .9.5/0.5 p.g/ml; and R, .16 ,ug/ml; and tetracycline: S, '1 ,ug/ml; MS, 2 to 8 ,ug/ml; and R, >8 ,Lg/ml. For rifampin, the criteria of Thornsberry et al. (20) were used: S, .2 ,ug/ml; MS, 4 ,ug/ml; and R, .8 ,ug/ml. In the absence of NCCLS recommendations for the newer antimicrobials agents, the following susceptibility breakpoints were used: ciproflox-ANTIMICROB. AGENTS CHEMOTHER.
acin, s1 ,ug/ml (10); enoxacin, -4 ,ug/ml (18); norfloxacin, '1 jig/ml (6); ofloxacin, <2 ,ug/ml (12) ; and roxithromycin, '<1 ,ug/ml (7).. The (21) . The low MIC90 of erythromycin confirms other reports (2, 5, 23) and supports the continued role of erythromycin as the antibiotic of choice for treating B. pertussis infections. SXT was also very effective, which supports its role in prophylaxis (1, 8, 11 For four isolates (6%), the MIC was above 0.12 ,ug/ml. All isolates were susceptible to ciprofloxacin and ofloxacin. Ciprofloxacin and ofloxacin were active against B. parapertussis. All strains were susceptible to these antimicrobial agents. Enoxacin and norfloxacin MIC90s were 1 and 0.5 ,ug/ml, respectively. All strains were susceptible to enoxacin, and for one strain (2%) the norfloxacin MIC was 2 ,ug/ml (resistant). The roxithromycin MIC90 was 2 ,ug/ml, which was fourfold higher than that observed for B. pertussis. The incidence of susceptibility was 76%, which was significantly lower than the 98% observed for B. pertussis isolates. The roxithromycin MIC5O was eightfold higher than the MIC90 observed with erythromycin. Overall, the MIC90s of the fluoroquinolones and roxithromycin for B. parapertussis were two-to fourfold higher than those observed for B. pertussis.
Although no B. bronchiseptica isolates were recovered in the Multicenter Pertussis Surveillance Project, they can occasionally be of significance in compromised patients (17) and animals and can carry R factors (19) . Only SXT showed relatively good activity against B. bronchiseptica, with 82% of the strains being susceptible (Table 1) . Even ciprofloxacin and enoxacin showed marginal activity. None of the isolates was susceptible to amoxicillin, erythromycin, rifampin, tetracycline, norfloxacin, and roxithromycin. The rates of moderate susceptibility to amoxicillin, erthromycin, rifampin, SXT, and erythromycin were 27, 27, 0, 87, and 18%, respectively. This pattern of resistance was extremely different from that of the other Bordetella species.
In summary, B. pertussis may be becoming more resistant to rifampin, tetracycline, and, to a lesser extent, amoxicillin. Tetracycline inhibited only 17% of the strains, while the remaining antimicrobial agents inhibited 93% or more of the strains. B. parapertussis strains were susceptible to erythromycin, SXT, and the fluoroquinolones. Only a small percentage (.2%) were susceptible to amoxicillin, rifampin, and tetracycline. Although the fluoroquinolones are very effective against B. pertussis and B. parapertussis, it is unlikely that they will be used in treating these infections in children. In vitro, roxithromycin does not appear to offer any advantage over erythromycin for either B. pertussis or B. parapertussis. B. bronchiseptica strains were distinct in that only SXT inhibited most (82%) of the strains.
